132335-47-8 (S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate)
1
Identification
| Smiles |
CN(C)CC[[email protected]](OC1=C2C=CC=CC2=CC=C1)C3=CC=CS3.O=C(O)C(O)=O |
| Synonyms |
S-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate; (S)-N,N-Dimethyl-g-(1-naphthalenyloxy)-2-thiophenepropanamine ethanedioate (1:1); (S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine oxalate |
| InChI |
InChI=1S/C19H21NOS.C2H2O4/c1-20(2)13-12-18(19-11-6-14-22-19)21-17-10-5-8-15-7-3-4-9-16(15)17;3-1(4)2(5)6/h3-11,14,18H,12-13H2,1-2H3;(H,3,4)(H,5,6)/t18-;/m0./s1 |
3
Protocol(Only for Reference)
Cell Experiment
Animal Experiment
4
Physical and Chemical Properties
| Appearance: |
EBNumber:EB000055437 |
Storage condition
Solubility
5
Mechanism and Indication
6
Clinical Information
| Product Name |
Sponsor & Collaborators |
Indications |
Start Date |
End Date |
Phase |
7
Safety Data of S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate
10
Related Products
Other Forms of 132335-47-8
Recommended Compounds in
Recommended Compounds in Same Indication
